Clinical Trial of Efficacy and Safety of Levopront® 30 mg/5 ml in Patients With Dry Cough

NCT03837938 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Cough

Interventions

DRUG: Levopront® syrup 30 mg/5 ml
DRUG: Libexin®

Sponsor

Dompé Farmaceutici S.p.A